[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.244.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Original Article
January 2003

Decrease of Collagen Deposition in Wound Repair in Type 1 Diabetes Independent of Glycemic Control

Author Affiliations

From the Copenhagen Wound Healing Center (Drs Black, Jorgensen, Holstein, and Gottrup) and the Medical Department I, Bispebjerg Hospital, University of Copenhagen (Drs Vibe-Petersen and Perrild), Copenhagen, Denmark; and Coloplast Research (Dr Madsen) and Aagren Dermaconsulting ApS (Dr [[Aring]]gren), Humleb[[aelig]]k, Denmark.

Arch Surg. 2003;138(1):34-40. doi:10.1001/archsurg.138.1.34
Abstract

Hypothesis  Type 1 and type 2 diabetes mellitus and glycemic control influence wound healing in humans.

Design  Experimental study using a human wound-healing model.

Setting  Collaboration among a multidisciplinary wound-healing department, department of medicine, and research laboratories.

Patients, Control Subjects, and Methods  In 34 patients with type 1 (insulin-dependent) and 25 with type 2 (non–insulin-dependent) diabetes and 5 nondiabetic control subjects matched with the type 2 diabetic patients, wound-healing capacity was determined as subcutaneous accumulation of collagen measured as hydroxyproline. Two expanded polytetrafluoroethylene tubes were implanted and removed 10 days later. The hydroxyproline level was determined by means of high-performance liquid chromatography; the collagenase activity, by using a radiolabeled collagen substrate. Proliferation of fibroblasts cultured from the wounds was studied in patient groups.

Results  The deposition of hydroxyproline decreased by 40% (P = .03) in type 1 compared with type 2 diabetes (median, 0.70 vs 1.16 nmol/mg; interquartile range, 0.48-1.04 vs 0.56-1.63 nmol/mg), which in turn did not differ significantly from that of controls (median, 1.35 nmol/mg; interquartile range, 0.72-1.88 nmol/mg). The decreased collagen deposition in type 1 diabetes was not caused by increased collagenase activity. The deposition of hydroxyproline did not correlate significantly (rs = 0.07; P = .63) with glycosylated hemoglobin levels in either diabetic group. Fibroblast growth was also decreased in type 1 compared with type 2 diabetic patients and controls.

Conclusions  Collagen deposition in acute wounds is impaired in type 1 diabetes, possibly due to a decreased fibroblast proliferation. In type 2 diabetes, collagen deposition is normal. Glycemic control does not influence collagen deposition in acute wound repair in type 1 or in type 2 diabetes mellitus.

×